-
$7M Grant Will Support Peptide Therapy for Cystic Fibrosis
ContraFect will receive up to $6.94 million in funding to develop their proprietary therapeutic peptides, a potential therapy for cystic fibrosis patients. Read more about this news here.
Are you excited about this potential new CF therapy?
Sorry, there were no replies found.
Log in to reply.